As of the latest SEC filings, CG Oncology, Inc. (CGON) is held by 307 institutional funds. The largest fund shareholder is T. Rowe Price Capital Appreciation Fund (PACLX), holding an estimated $174,267,066.24 in market value, representing 0.26% of its portfolio.
Funds holding CG Oncology, Inc. (CGON)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- CGON
- CIK:
- 0001991792
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
PACLX
T. Rowe Price Capital Appreciation Fund
|
MF | T. Rowe Price | 0.26% | $174,267,066.24 | 2,574,868 | Mar 31, 2026 | May 28, 2026 |
|
VGHAX
VANGUARD HEALTH CARE FUND
|
MF | Vanguard | 0.47% | $172,806,411.52 | 2,589,248 | Apr 30, 2026 | Jun 26, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.01% | $148,504,674.24 | 2,194,218 | Mar 31, 2026 | May 28, 2026 |
|
NAESX
VANGUARD SMALL-CAP INDEX FUND
|
ETF | Vanguard | 0.07% | $106,996,056.48 | 1,580,911 | Mar 31, 2026 | May 28, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.14% | $97,710,022.08 | 1,443,706 | Mar 31, 2026 | May 28, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 1.16% | $86,421,945.60 | 1,276,920 | Mar 31, 2026 | May 28, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 0.69% | $75,028,220.64 | 1,108,573 | Mar 31, 2026 | May 28, 2026 |
|
VISVX
VANGUARD SMALL-CAP VALUE INDEX FUND
|
ETF | Vanguard | 0.11% | $68,137,719.84 | 1,006,763 | Mar 31, 2026 | May 28, 2026 |
|
FIDGX
Fidelity Small Cap Growth Fund
|
MF | Fidelity | 0.63% | $53,221,212.34 | 797,441 | Apr 30, 2026 | Jun 26, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.06% | $51,761,596.32 | 764,799 | Mar 31, 2026 | May 28, 2026 |
|
PAMCX
T. Rowe Price Mid-Cap Growth Fund, Inc.
|
MF | T. Rowe Price | 0.22% | $50,441,565.60 | 745,295 | Mar 31, 2026 | May 28, 2026 |
|
PRJIX
T. Rowe Price New Horizons Fund, Inc.
|
MF | T. Rowe Price | 0.39% | $50,240,759.04 | 742,328 | Mar 31, 2026 | May 28, 2026 |
|
FSPHX
Select Health Care Portfolio
|
MF | Fidelity | 0.76% | $47,040,000.00 | 800,000 | Feb 28, 2026 | Apr 24, 2026 |
|
PRDSX
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund
|
MF | T. Rowe Price | 0.52% | $42,758,938.08 | 631,781 | Mar 31, 2026 | May 28, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.12% | $39,031,954.64 | 584,836 | Apr 30, 2026 | Jun 26, 2026 |
|
-
JNL/T. Rowe Price Capital Appreciation Fund
|
ETF | Independent / Boutique | 0.28% | $38,567,515.68 | 569,851 | Mar 31, 2026 | May 28, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.27% | $32,703,788.16 | 483,212 | Mar 31, 2026 | May 28, 2026 |
|
FOCSX
Fidelity Small Cap Growth K6 Fund
|
MF | Fidelity | 0.75% | $32,057,824.86 | 480,339 | Apr 30, 2026 | Jun 26, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.32% | $25,670,685.60 | 379,295 | Mar 31, 2026 | May 28, 2026 |
|
ETAHX
Eventide Healthcare & Life Sciences Fund
|
MF | Independent / Boutique | 1.56% | $24,797,748.96 | 366,397 | Mar 31, 2026 | May 29, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.05% | $21,042,285.60 | 357,862 | Feb 28, 2026 | Apr 24, 2026 |
|
QUAZX
AB Small Cap Growth Portfolio
|
MF | Independent / Boutique | 0.72% | $20,988,662.16 | 314,484 | Apr 30, 2026 | Jun 24, 2026 |
|
OTCFX
T. Rowe Price Small-Cap Stock Fund, Inc.
|
MF | T. Rowe Price | 0.26% | $20,650,792.32 | 305,124 | Mar 31, 2026 | May 28, 2026 |
|
FCTDX
Strategic Advisers Fidelity U.S. Total Stock Fund
|
MF | Fidelity | 0.01% | $20,334,804.00 | 345,830 | Feb 28, 2026 | Apr 24, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.09% | $19,547,236.80 | 332,436 | Feb 28, 2026 | Apr 24, 2026 |
Advertisement (320x50)